A Study Evaluating the Efficacy and Safety of AG-348 in Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)
Clinical trial NCT03559699 · COMPLETED
Trial details
- NCT number
- NCT03559699
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-26
- Primary completion
- 2020-11-12
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.